Literature DB >> 21502988

An unexpected role for MHC class II.

Ghada S Hassan, Walid Mourad.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21502988     DOI： 10.1038/ni.2023

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  12 in total

1.  Expression of MHC class II molecules contributes to lipopolysaccharide responsiveness.

Authors:  A Piani; J P Hossle; T Birchler; C A Siegrist; D Heumann; G Davies; S Loeliger; R Seger; R P Lauener
Journal:  Eur J Immunol       Date:  2000-11       Impact factor: 5.532

Review 2.  MHC class II signaling in antigen-presenting cells.

Authors:  Reem Al-Daccak; Nuala Mooney; Dominique Charron
Journal:  Curr Opin Immunol       Date:  2004-02       Impact factor: 7.486

3.  Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo.

Authors:  Phillip J Sanchez; Jennifer A McWilliams; Catherine Haluszczak; Hideo Yagita; Ross M Kedl
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

Review 4.  Localisation and trafficking of Toll-like receptors: an important mode of regulation.

Authors:  Anne F McGettrick; Luke A J O'Neill
Journal:  Curr Opin Immunol       Date:  2010-01-07       Impact factor: 7.486

Review 5.  TLR signalling regulated antigen presentation in dendritic cells.

Authors:  Colin Watts; Michele A West; Rossana Zaru
Journal:  Curr Opin Immunol       Date:  2010-01-18       Impact factor: 7.486

6.  Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk.

Authors:  Xingguang Liu; Zhenzhen Zhan; Dong Li; Li Xu; Feng Ma; Peng Zhang; Hangping Yao; Xuetao Cao
Journal:  Nat Immunol       Date:  2011-03-27       Impact factor: 25.606

7.  Synergistic effect between CD40 and class II signals overcome the requirement for class II dimerization in superantigen-induced cytokine gene expression.

Authors:  K Mehindate; R al-Daccak; F Damdoumi; W Mourad
Journal:  Eur J Immunol       Date:  1996-09       Impact factor: 5.532

8.  IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.

Authors:  Moritz Wagner; Hendrik Poeck; Bernd Jahrsdoerfer; Simon Rothenfusser; Domenik Prell; Barbara Bohle; Evelyn Tuma; Thomas Giese; Joachim W Ellwart; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

9.  Activation of MyD88 signaling upon staphylococcal enterotoxin binding to MHC class II molecules.

Authors:  Teri L Kissner; Gordon Ruthel; Shahabuddin Alam; Robert G Ulrich; Stefan Fernandez; Kamal U Saikh
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

10.  MHC class II molecules enhance Toll-like receptor mediated innate immune responses.

Authors:  Remo Frei; Johanna Steinle; Thomas Birchler; Susanne Loeliger; Caroline Roduit; Dirk Steinhoff; Reinhart Seibl; Katja Büchner; Reinhard Seger; Walter Reith; Roger P Lauener
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240
View more
  12 in total

Review 1.  Highlights of the advances in basic immunology in 2011.

Authors:  Juan Liu; Shuxun Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2012-04-23       Impact factor: 11.530

2.  A small molecule that mimics the BB-loop in the Toll interleukin-1 (IL-1) receptor domain of MyD88 attenuates staphylococcal enterotoxin B-induced pro-inflammatory cytokine production and toxicity in mice.

Authors:  Teri L Kissner; Lionel Moisan; Enrique Mann; Shahabuddin Alam; Gordon Ruthel; Robert G Ulrich; Mitra Rebek; Julius Rebek; Kamal U Saikh
Journal:  J Biol Chem       Date:  2011-06-21       Impact factor: 5.157

Review 3.  Intracellular nucleic acid sensors and autoimmunity.

Authors:  Argyrios N Theofilopoulos; Dwight H Kono; Bruce Beutler; Roberto Baccala
Journal:  J Interferon Cytokine Res       Date:  2011-10-27       Impact factor: 2.607

Review 4.  Differential roles of resident microglia and infiltrating monocytes in murine CNS autoimmunity.

Authors:  Anat Shemer; Steffen Jung
Journal:  Semin Immunopathol       Date:  2015-08-04       Impact factor: 9.623

5.  HLA Class II-Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection.

Authors:  Yi-Ping Jin; Nicole M Valenzuela; Xiaohai Zhang; Enrique Rozengurt; Elaine F Reed
Journal:  J Immunol       Date:  2018-02-23       Impact factor: 5.422

6.  Hyperglycemia and dyslipidemia: Reduced HLA-DR expression in monocyte subpopulations from diabetes patients.

Authors:  Blanca I Restrepo; Marcel Twahirwa; Chinnaswamy Jagannath
Journal:  Hum Immunol       Date:  2020-12-08       Impact factor: 2.211

7.  Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88.

Authors:  Teri L Kissner; Gordon Ruthel; Shahabuddin Alam; Enrique Mann; Dariush Ajami; Mitra Rebek; Eileen Larkin; Stefan Fernandez; Robert G Ulrich; Sun Ping; David S Waugh; Julius Rebek; Kamal U Saikh
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

8.  Discovery of small molecule inhibitors of MyD88-dependent signaling pathways using a computational screen.

Authors:  Mark A Olson; Michael S Lee; Teri L Kissner; Shahabuddin Alam; David S Waugh; Kamal U Saikh
Journal:  Sci Rep       Date:  2015-09-18       Impact factor: 4.379

9.  New frontiers for platelet CD154.

Authors:  Antoine Dewitte; Annabelle Tanga; Julien Villeneuve; Sébastien Lepreux; Alexandre Ouattara; Alexis Desmoulière; Christian Combe; Jean Ripoche
Journal:  Exp Hematol Oncol       Date:  2015-03-01

10.  Small Molecule Analogues of the parasitic worm product ES-62 interact with the TIR domain of MyD88 to inhibit pro-inflammatory signalling.

Authors:  Colin J Suckling; Shahabuddin Alam; Mark A Olson; Kamal U Saikh; Margaret M Harnett; William Harnett
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.